UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000008389 |
|---|---|
| Receipt number | R000009860 |
| Scientific Title | Phase II study of Trastuzuman in combination with TS-1 and Cisplatin for patients with Human Epidermal Growth Facter Receptor type-2 (HER-2)-positive Advanced Gastric Cancer |
| Date of disclosure of the study information | 2012/07/09 |
| Last modified on | 2017/08/10 16:11:37 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/07/09 17:21:44 | ||
| 2 | Update | 2012/11/09 13:23:59 | Recruitment status |
|
| 3 | Update | 2012/11/09 13:31:08 | Institutions |
|
| 4 | Update | 2013/06/03 09:11:03 | Target sample size |
|
| 5 | Update | 2014/01/31 19:20:33 | Recruitment status |
|
| 6 | Update | 2016/02/25 09:31:25 | Recruitment status |
|
| 7 | Update | 2016/02/25 09:31:41 | Publication of results |
|
| 8 | Update | 2017/08/10 16:11:37 | URL related to results and publications |
